Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 90 member A16 (FAM90A16) is a human gene with multiple transcript variants, classified predominantly as a protein-coding gene but often flagged as a possible pseudogene due to limited evidence of translation and lack of characterized protein function. There are no described molecular functions, disease roles, or relevance as a drug target. FAM90A16 belongs to a gene family with several paralogs, many with uncertain or disputed protein-coding status, and no established biological or therapeutic significance. Major databases (GeneCards, UniProt, HGNC) list FAM90A16 as protein-coding, though some entries (historical) use the "FAM90A16P" suffix indicating pseudogene annotation. There is no experimental evidence for protein function, tissue specificity, disease linkage, protein expression, involvement in molecular pathways, or relevance to cell biology or medicine. The gene has four exons and is manually annotated as being on the forward strand. FAM90A16 is best classified as a gene with disputed protein-coding status, possible pseudogene annotation, and no known functional or therapeutic relevance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 90 member A16 (FAM90A16).